Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CC-4047: 114 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
114
Total FAERS Reports
65 (57.0%)
Deaths Reported
49
Hospitalizations
114
As Primary/Secondary Suspect
14
Life-Threatening
6
Disabilities

First Report: 20120206 · Latest Report: 20140515

What Are the Most Common CC-4047 Side Effects?

#1 Most Reported
Plasma cell myeloma
42 reports (36.8%)
#2 Most Reported
Death
13 reports (11.4%)
#3 Most Reported
Thrombocytopenia
10 reports (8.8%)

All CC-4047 Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Plasma cell myeloma 42 36.8% 35 9
Death 13 11.4% 13 1
Neutropenia 10 8.8% 7 2
Thrombocytopenia 10 8.8% 6 3
Anaemia 8 7.0% 4 2
Pneumonia 8 7.0% 5 7
Leukopenia 6 5.3% 3 2
Febrile neutropenia 5 4.4% 1 5
Neutrophil count decreased 5 4.4% 2 2
Pancytopenia 5 4.4% 1 4
Renal failure acute 5 4.4% 3 4

Who Reports CC-4047 Side Effects? Age & Gender Data

Average age: 67.0 years. Most reports from: FR. View detailed demographics →

Is CC-4047 Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 9 6 4
2013 56 33 26
2014 24 9 17

View full timeline →

What Is CC-4047 Used For?

IndicationReports
Plasma cell myeloma 105

CC-4047 vs Alternatives: Which Is Safer?

CC-4047 vs CEDAZURIDINE\DECITABINE CC-4047 vs CEDIRANIB CC-4047 vs CEFACLOR CC-4047 vs CEFADROXIL CC-4047 vs CEFAZOLIN CC-4047 vs CEFDINIR CC-4047 vs CEFEPIME CC-4047 vs CEFEPIME\CEFEPIME CC-4047 vs CEFIDEROCOL CC-4047 vs CEFIXIME

Official FDA Label for CC-4047

Official prescribing information from the FDA-approved drug label.